3018 – DETERMINING THE VARIATIONS OF THE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN CANCER PATIENTS - A PROSPECTIVE STUDY

IF 2.5 4区 医学 Q2 HEMATOLOGY Experimental hematology Pub Date : 2024-08-01 DOI:10.1016/j.exphem.2024.104340
Goodness Njoku , Vaidehi Joshi , Abhishek Reddy , Sumalatha Kasturi , Santosh Rendla , Suma Alluri
{"title":"3018 – DETERMINING THE VARIATIONS OF THE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN CANCER PATIENTS - A PROSPECTIVE STUDY","authors":"Goodness Njoku ,&nbsp;Vaidehi Joshi ,&nbsp;Abhishek Reddy ,&nbsp;Sumalatha Kasturi ,&nbsp;Santosh Rendla ,&nbsp;Suma Alluri","doi":"10.1016/j.exphem.2024.104340","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>:Neutrophil-Lymphocyte Ratio (NLR), a simple marker to assess immune response (IR) is derived by dividing absolute neutrophil count (ANC) by absolute lymphocyte count (ALC) obtained through a routine complete blood cell count (CBC). Neutrophils, an integral part of the innate IR, are tumour promoting and immune suppressive role. Neutrophilia is usually accompanied by relative lymphocytopenia representing a significant decline in cell-mediated adaptive IR consequently promoting metastasis.</p></div><div><h3>Methods</h3><p>CBC and Histopathology reports of carcinomas patients in a 2-year period. The ANC and ALC obtained were used to calculate the NLR. Inclusion Criteria: patients with cancer and NLR calculated from the CBC prior to surgery. Exclusion criteria: Cancer patients with any infection or inflammatory process , febrile patients and those on chemotherapy</p></div><div><h3>Results</h3><p>58 patients (33 females and 25 males) Mean age patients in males and females were 54.2 and 56.78 respectively. In male and female patients with NLR above 10, the most prevalent cancer was in the rectum and the buccal mucosa, respectively. Male patients with stages T0N0M0- T2N1M0 had lower NLR values in the 3.428 to 9.44 range. Male patients with T3N0M0-T4N1M0 stage had an NLR range of 2.54 to 6.38. In the female patients with NLR above 10, two have tongue cancer with staging from T2N0M0-T4bN2M0 and one buccal mucosal cancer patient with T4N2cM0. The lower values of the NLR is more prevalent in female patients with breast cancer.</p></div><div><h3>Conclusion</h3><p>Rectosigmoid cancer had the highest NLR. Buccal mucosa and tongue cancers had lower NLR, with few outliers. The lowest NLR was seen in breast cancer patients, showing a possible gender correlation. Regarding prognosis, our data suggests that age and gender of the patient, anatomic location and the TNM of the cancer are significant.</p></div>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":"137 ","pages":"Article 104340"},"PeriodicalIF":2.5000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0301472X24001991/pdfft?md5=89dc48460cdc1d765773c68e0025a338&pid=1-s2.0-S0301472X24001991-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental hematology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0301472X24001991","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

:Neutrophil-Lymphocyte Ratio (NLR), a simple marker to assess immune response (IR) is derived by dividing absolute neutrophil count (ANC) by absolute lymphocyte count (ALC) obtained through a routine complete blood cell count (CBC). Neutrophils, an integral part of the innate IR, are tumour promoting and immune suppressive role. Neutrophilia is usually accompanied by relative lymphocytopenia representing a significant decline in cell-mediated adaptive IR consequently promoting metastasis.

Methods

CBC and Histopathology reports of carcinomas patients in a 2-year period. The ANC and ALC obtained were used to calculate the NLR. Inclusion Criteria: patients with cancer and NLR calculated from the CBC prior to surgery. Exclusion criteria: Cancer patients with any infection or inflammatory process , febrile patients and those on chemotherapy

Results

58 patients (33 females and 25 males) Mean age patients in males and females were 54.2 and 56.78 respectively. In male and female patients with NLR above 10, the most prevalent cancer was in the rectum and the buccal mucosa, respectively. Male patients with stages T0N0M0- T2N1M0 had lower NLR values in the 3.428 to 9.44 range. Male patients with T3N0M0-T4N1M0 stage had an NLR range of 2.54 to 6.38. In the female patients with NLR above 10, two have tongue cancer with staging from T2N0M0-T4bN2M0 and one buccal mucosal cancer patient with T4N2cM0. The lower values of the NLR is more prevalent in female patients with breast cancer.

Conclusion

Rectosigmoid cancer had the highest NLR. Buccal mucosa and tongue cancers had lower NLR, with few outliers. The lowest NLR was seen in breast cancer patients, showing a possible gender correlation. Regarding prognosis, our data suggests that age and gender of the patient, anatomic location and the TNM of the cancer are significant.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
3018 - 确定癌症患者中性粒细胞与淋巴细胞比率(NLR)的变化 - 一项前瞻性研究
背景:中性粒细胞-淋巴细胞比值(NLR)是评估免疫反应(IR)的一个简单标记,它是通过常规全血细胞计数(CBC)获得的绝对中性粒细胞计数(ANC)除以绝对淋巴细胞计数(ALC)得出的。中性粒细胞是先天性免疫反应不可或缺的一部分,具有促进肿瘤生长和抑制免疫的作用。中性粒细胞增多通常伴有相对淋巴细胞减少,这表明细胞介导的适应性红细胞减少,从而促进肿瘤转移。用获得的 ANC 和 ALC 计算 NLR。纳入标准:癌症患者,手术前通过 CBC 计算 NLR。排除标准:结果 58 名患者(33 名女性和 25 名男性)中,男性和女性患者的平均年龄分别为 54.2 岁和 56.78 岁。在 NLR 超过 10 的男性和女性患者中,直肠癌和口腔黏膜癌的发病率最高。T0N0M0-T2N1M0期男性患者的NLR值较低,在3.428至9.44之间。T3N0M0-T4N1M0 期男性患者的 NLR 值范围为 2.54 至 6.38。在 NLR 值超过 10 的女性患者中,有两名舌癌患者的分期为 T2N0M0-T4bN2M0,一名口腔粘膜癌患者的分期为 T4N2cM0。结论直肠乙状结肠癌的 NLR 值最高。直肠乙状结肠癌的 NLR 值最高,口腔粘膜癌和舌癌的 NLR 值较低,但异常值较少。乳腺癌患者的 NLR 最低,这可能与性别有关。在预后方面,我们的数据表明,患者的年龄和性别、解剖位置和癌症的 TNM 非常重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Experimental hematology
Experimental hematology 医学-血液学
CiteScore
5.30
自引率
0.00%
发文量
84
审稿时长
58 days
期刊介绍: Experimental Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation on a monthly basis that may include Special Issues on particular topics of current interest. The overall goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment. Specific topics may include relevant developmental and aging processes, stem cell biology, analyses of intrinsic and extrinsic regulatory mechanisms, in vitro behavior of primary cells, clonal tracking, molecular and omics analyses, metabolism, epigenetics, bioengineering approaches, studies in model organisms, novel clinical observations, transplantation biology and new therapeutic avenues.
期刊最新文献
FT-4202, a selective pyruvate kinase R activator for sickle cell disease. Structural diversity and function of the granulocyte colony-stimulating factor in medaka fish. Platelet ultrastructural changes stored at room temperature versus cold storage observed by electron microscopy and structured illumination microscopy. Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia Inducible pluripotent stem cell models to study bone marrow failure and MDS predisposition syndromes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1